NCT01625351 2026-02-06
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
St. Jude Children's Research Hospital
Phase 1 Completed
Clinical Trials
9 trialsNCT01010126 2019-01-25
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01522820 2016-10-04
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Roswell Park Cancer Institute
Phase 1 Completed
NCT01374750 2016-06-01
Sirolimus
Seoul National University Hospital
Phase 2 Completed
NCT02724332 2016-03-31
Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC
Eastern Hepatobiliary Surgery Hospital
Phase 1 Completed
NCT00355862 2014-07-30
Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
University of Regensburg
Phase 3 Completed
NCT00328770 2013-06-24
De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
University of Alberta
Phase 2/3 Completed
NCT00467194 2013-06-17
Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
National Cancer Centre, Singapore
Phase 1 Completed
NCT00554125 2007-11-06
Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria
Fudan University
Phase 3 Unknown